+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Pressure Ulcers Drug"

From
From
Pressure Ulcers - Pipeline Insight, 2024 - Product Thumbnail Image

Pressure Ulcers - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
From
Pressure Ulcers - Epidemiology Forecast to 2032 - Product Thumbnail Image

Pressure Ulcers - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Pressure Ulcers (Dermatology) - Drugs In Development, 2021 - Product Thumbnail Image

Pressure Ulcers (Dermatology) - Drugs In Development, 2021

  • Drug Pipelines
  • June 2021
  • 30 Pages
  • Global
From
Pressure Ulcers - Pipeline Review, H2 2020 - Product Thumbnail Image

Pressure Ulcers - Pipeline Review, H2 2020

  • Drug Pipelines
  • August 2020
  • 32 Pages
  • Global
From
  • 11 Results (Page 1 of 1)
Loading Indicator

Pressure ulcers, also known as bedsores, are localized areas of tissue damage caused by prolonged pressure on the skin. They are a common complication of immobility and are particularly common in elderly people and those with chronic illnesses. Treatment of pressure ulcers typically involves the use of topical medications, such as creams, ointments, and gels, as well as systemic medications, such as antibiotics and antifungals. The pressure ulcers drug market is a subset of the larger dermatological drugs market. It includes a range of products designed to treat and prevent pressure ulcers, including topical medications, systemic medications, and dressings. These products are used in both inpatient and outpatient settings, and are typically prescribed by a physician. The pressure ulcers drug market is highly competitive, with a number of large pharmaceutical companies competing for market share. Some of the major players in the market include Pfizer, Johnson & Johnson, Merck, Novartis, and GlaxoSmithKline. Show Less Read more